Skip to main content

Animations

MJFF Publications

5291 - 5300 of 7915 Results
Title
Year
  • Year
  • 2018
  • 2018
  • 2018
  • 2018
  • 2018
  • 2018
  • 2018
  • 2018
  • 2018
  • 2018
  • OPEN
    Title: Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson's disease and DLB
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1073/pnas.1813365115
    Citation Count: 68
  • OPEN
    Title: Characterizing patient compliance over six months in remote digital trials of Parkinson’s and Huntington disease
    Journal Name: BMC Medical Informatics and Decision Making
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12911-018-0714-7
    Citation Count: 32
  • OPEN
    Title: Destabilizing Domains Enable Long-Term and Inert Regulation of GDNF Expression in the Brain
    Journal Name: Molecular Therapy - Methods & Clinical Development
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.omtm.2018.08.008
    Citation Count: 16
  • OPEN
    Title: The atypical RhoGTPase RhoE/Rnd3 is a key molecule to acquire a neuroprotective phenotype in microglia
    Journal Name: Journal of Neuroinflammation
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12974-018-1386-z
    Citation Count: 14
  • OPEN
    Title: CoREST Complex-Selective Histone Deacetylase Inhibitors Show Prosynaptic Effects and an Improved Safety Profile To Enable Treatment of Synaptopathies
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1021/acschemneuro.8b00620
    Citation Count: 37
  • OPEN
    Title: Parkinson-Associated SNCA Enhancer Variants Revealed by Open Chromatin in Mouse Dopamine Neurons
    Journal Name: The American Journal of Human Genetics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.ajhg.2018.10.018
    Citation Count: 34
  • OPEN
    Title: A paradoxical relationship between family history, onset age, and genetic risk in Parkinson's disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27555
    Citation Count: 3
  • OPEN
    Title: Computational affinity maturation of camelid single-domain intrabodies against the nonamyloid component of alpha-synuclein
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-018-35464-7
    Citation Count: 38
  • OPEN
    Title: Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia
    Journal Name: Nature Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41591-018-0223-3
    Citation Count: 121
  • RESTRICTED
    Title: Normal and pathological neuronal distribution of the human mesencephalic locomotor region
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27578
    Best OA location URL:
    Citation Count: 32
Filters
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.